Qiagen Joins Global Initiative to Develop MDx for World's Poorest Countries | GenomeWeb

NEW YORK (GenomeWeb News) – Qiagen today said it has joined a global initiative to develop affordable and portable molecular diagnostics for resource-poor regions of the world.

The Point-of-Care Diagnostics Initiative is led by the Bill and Melinda Gates Foundation and Grand Challenges Canada and targets the development of new molecular diagnostic platforms to improve healthcare in the poorest regions of the world. Qiagen joins more than 20 other non-profits, academic, and corporate organizations in the initiative.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.